Please enable JavaScript to continue using this application.

Compare $CDNA vs $PBLS | Chartloom

Compare

$CDNA vs $PBLS

CareDx Inc · Parabilis Medicines Inc

CDNA

CareDx Inc

PBLS

Parabilis Medicines Inc

Compare $CDNA vs $PBLS

Comparing CareDx Inc and Parabilis Medicines Inc

CDNACareDx Inc

PBLSParabilis Medicines Inc

CDNACareDx Inc

Market cap

$3.29B

P/E (TTM)

30.64x

Forward P/E (NTM)

57.50x

Forward P/S (NTM)

6.55x

Rev growth (TTM)

34.4%

YTD performance

232.7%

52W performance

330.5%

FCF yield

2.6%

PBLSParabilis Medicines Inc

Market cap

$3.20B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

581.53x

Rev growth (TTM)

—

YTD performance

-13.0%

52W performance

-13.0%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CDNA

PBLS

Detailed metrics comparison

CDNA

CareDx Inc

PBLS

Parabilis Medicines Inc

Market Cap

CDNA$3.29B

PBLS$3.20B

Enterprise Value

CDNA$2.92B

PBLS$2.12B

Price

CDNA$63.67

PBLS$27.48

P/E Ratio

CDNA30.64x

PBLSN/A

P/S Ratio

CDNA7.18x

PBLS21,642.36x

EV/Sales

CDNA6.36x

PBLS14,348.08x

EV/EBITDA

CDNA23.24x

PBLS0.00x

P/B Ratio

CDNA8.16x

PBLS3.57x

P/FCF Ratio

CDNA39.14x

PBLSN/A

EV/FCF

CDNA34.70x

PBLS-39.47x

PEG Ratio

CDNA0.31x

PBLSN/A

Forward P/E (NTM)

CDNA57.50x

PBLSN/A

Forward P/S (NTM)

CDNA6.55x

PBLS581.53x

Revenue (TTM)

CDNA$458M

PBLS$148K

Revenue Growth (YoY)

CDNA34.4%

PBLSN/A

Forward Rev Growth

CDNA7.0%

PBLS212.5%

Gross Margin (TTM)

CDNA70.6%

PBLS0.0%

Operating Margin (TTM)

CDNA23.6%

PBLS0.0%

EBITDA Margin (TTM)

CDNA27.4%

PBLS-65635.1%

Net Margin (TTM)

CDNA24.2%

PBLS-93131.8%

FCF Margin (TTM)

CDNA18.3%

PBLS-36356.1%

Net Income (TTM)

CDNA$111M

PBLS$-138M

FCF (TTM)

CDNA$84M

PBLS$-54M

EPS (TTM)

CDNA$2.08

PBLS-$1.12

ROE (TTM)

CDNA32.8%

PBLS0.0%

ROA (TTM)

CDNA24.8%

PBLS0.0%

ROIC (TTM)

CDNA32.8%

PBLS0.0%

Cash

CDNA$374M

PBLS$1.09B

Debt

CDNA$0

PBLS$8M

Net Cash/Debt

CDNA$374M

PBLS$1.08B

Current Ratio (TTM)

CDNA4.58x

PBLS17.91x

Quick Ratio (TTM)

CDNA4.35x

PBLS17.83x

Debt/Equity (TTM)

CDNA0.00x

PBLS0.01x

Debt/Assets (TTM)

CDNA0.0%

PBLS0.0%

Interest Coverage (TTM)

CDNAN/A

PBLSN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

PBLS0.00x

Beta

CDNA2.58

PBLS-1.08

52W Performance

CDNA330.5%

PBLS-13.0%

YTD Performance

CDNA232.7%

PBLS-13.0%

% from 52W High

CDNA-12.2%

PBLS-35.3%

% from 52W Low

CDNA356.4%

PBLS12.1%

Asset Turnover (TTM)

CDNA1.02x

PBLS0.00x

FCF Yield (TTM)

CDNA2.6%

PBLS-1.7%

Earnings Yield (TTM)

CDNA3.4%

PBLS-4.3%

Dividend Yield (TTM)

CDNAN/A

PBLSN/A

Rule of 40

CDNA52.7

PBLS-36,356.1

EV/GP/RG

CDNA0.94

PBLSN/A

Ticker research

View CDNA research View PBLS research

Metric	CDNA CareDx Inc	PBLS Parabilis Medicines Inc
Market & Valuation
Market Cap	$3.29B	$3.20B
Enterprise Value	$2.92B	$2.12B
Price	$63.67	$27.48
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	21,642.36x
EV/Sales	6.36x	14,348.08x
EV/EBITDA	23.24x	0.00x
P/B Ratio	8.16x	3.57x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-39.47x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	N/A
Forward P/S (NTM)	6.55x	581.53x
Revenue & Growth
Revenue (TTM)	$458M	$148K
Revenue Growth (YoY)	34.4%	N/A
Forward Rev Growth	7.0%	212.5%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-65635.1%
Net Margin (TTM)	24.2%	-93131.8%
FCF Margin (TTM)	18.3%	-36356.1%
Net Income (TTM)	$111M	$-138M
FCF (TTM)	$84M	$-54M
EPS (TTM)	$2.08	-$1.12
ROE (TTM)	32.8%	0.0%
ROA (TTM)	24.8%	0.0%
ROIC (TTM)	32.8%	0.0%
Financial Health
Cash	$374M	$1.09B
Debt	$0	$8M
Net Cash/Debt	$374M	$1.08B
Current Ratio (TTM)	4.58x	17.91x
Quick Ratio (TTM)	4.35x	17.83x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	-1.08
52W Performance	330.5%	-13.0%
YTD Performance	232.7%	-13.0%
% from 52W High	-12.2%	-35.3%
% from 52W Low	356.4%	12.1%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.00x
FCF Yield (TTM)	2.6%	-1.7%
Earnings Yield (TTM)	3.4%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	-36,356.1
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View PBLS research

Valuation

P/E Ratio

CDNA

30.64x

P/S Ratio

CDNA

7.18x

PBLS

21,642.36x

EV/FCF

PBLS

-39.47x

CDNA

34.70x

Growth & revenue

Revenue Growth TTM

CDNA

34.4%

Forward Revenue Growth

PBLS

212.5%

CDNA

7.0%

Profitability & performance

Gross Margin

CDNA

70.6%

PBLS

0.0%

ROE

CDNA

32.8%

PBLS

0.0%

FCF Yield %

CDNA

2.6%

PBLS

-1.7%

52-Week Performance

CDNA

330.5%

PBLS

-13.0%

Detailed metrics comparison

CDNA

CareDx Inc

PBLS

Parabilis Medicines Inc

Market Cap

CDNA$3.29B

PBLS$3.20B

Enterprise Value

CDNA$2.92B

PBLS$2.12B

Price

CDNA$63.67

PBLS$27.48

P/E Ratio

CDNA30.64x

PBLSN/A

P/S Ratio

CDNA7.18x

PBLS21,642.36x

EV/Sales

CDNA6.36x

PBLS14,348.08x

EV/EBITDA

CDNA23.24x

PBLS0.00x

P/B Ratio

CDNA8.16x

PBLS3.57x

P/FCF Ratio

CDNA39.14x

PBLSN/A

EV/FCF

CDNA34.70x

PBLS-39.47x

PEG Ratio

CDNA0.31x

PBLSN/A

Forward P/E (NTM)

CDNA57.50x

PBLSN/A

Forward P/S (NTM)

CDNA6.55x

PBLS581.53x

Revenue (TTM)

CDNA$458M

PBLS$148K

Revenue Growth (YoY)

CDNA34.4%

PBLSN/A

Forward Rev Growth

CDNA7.0%

PBLS212.5%

Gross Margin (TTM)

CDNA70.6%

PBLS0.0%

Operating Margin (TTM)

CDNA23.6%

PBLS0.0%

EBITDA Margin (TTM)

CDNA27.4%

PBLS-65635.1%

Net Margin (TTM)

CDNA24.2%

PBLS-93131.8%

FCF Margin (TTM)

CDNA18.3%

PBLS-36356.1%

Net Income (TTM)

CDNA$111M

PBLS$-138M

FCF (TTM)

CDNA$84M

PBLS$-54M

EPS (TTM)

CDNA$2.08

PBLS-$1.12

ROE (TTM)

CDNA32.8%

PBLS0.0%

ROA (TTM)

CDNA24.8%

PBLS0.0%

ROIC (TTM)

CDNA32.8%

PBLS0.0%

Cash

CDNA$374M

PBLS$1.09B

Debt

CDNA$0

PBLS$8M

Net Cash/Debt

CDNA$374M

PBLS$1.08B

Current Ratio (TTM)

CDNA4.58x

PBLS17.91x

Quick Ratio (TTM)

CDNA4.35x

PBLS17.83x

Debt/Equity (TTM)

CDNA0.00x

PBLS0.01x

Debt/Assets (TTM)

CDNA0.0%

PBLS0.0%

Interest Coverage (TTM)

CDNAN/A

PBLSN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

PBLS0.00x

Beta

CDNA2.58

PBLS-1.08

52W Performance

CDNA330.5%

PBLS-13.0%

YTD Performance

CDNA232.7%

PBLS-13.0%

% from 52W High

CDNA-12.2%

PBLS-35.3%

% from 52W Low

CDNA356.4%

PBLS12.1%

Asset Turnover (TTM)

CDNA1.02x

PBLS0.00x

FCF Yield (TTM)

CDNA2.6%

PBLS-1.7%

Earnings Yield (TTM)

CDNA3.4%

PBLS-4.3%

Dividend Yield (TTM)

CDNAN/A

PBLSN/A

Rule of 40

CDNA52.7

PBLS-36,356.1

EV/GP/RG

CDNA0.94

PBLSN/A

Ticker research

View CDNA research View PBLS research

Metric	CDNA CareDx Inc	PBLS Parabilis Medicines Inc
Market & Valuation
Market Cap	$3.29B	$3.20B
Enterprise Value	$2.92B	$2.12B
Price	$63.67	$27.48
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	21,642.36x
EV/Sales	6.36x	14,348.08x
EV/EBITDA	23.24x	0.00x
P/B Ratio	8.16x	3.57x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-39.47x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	N/A
Forward P/S (NTM)	6.55x	581.53x
Revenue & Growth
Revenue (TTM)	$458M	$148K
Revenue Growth (YoY)	34.4%	N/A
Forward Rev Growth	7.0%	212.5%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-65635.1%
Net Margin (TTM)	24.2%	-93131.8%
FCF Margin (TTM)	18.3%	-36356.1%
Net Income (TTM)	$111M	$-138M
FCF (TTM)	$84M	$-54M
EPS (TTM)	$2.08	-$1.12
ROE (TTM)	32.8%	0.0%
ROA (TTM)	24.8%	0.0%
ROIC (TTM)	32.8%	0.0%
Financial Health
Cash	$374M	$1.09B
Debt	$0	$8M
Net Cash/Debt	$374M	$1.08B
Current Ratio (TTM)	4.58x	17.91x
Quick Ratio (TTM)	4.35x	17.83x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	-1.08
52W Performance	330.5%	-13.0%
YTD Performance	232.7%	-13.0%
% from 52W High	-12.2%	-35.3%
% from 52W Low	356.4%	12.1%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.00x
FCF Yield (TTM)	2.6%	-1.7%
Earnings Yield (TTM)	3.4%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	-36,356.1
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View PBLS research